PL1833477T3 - Związki pirazolo-heteroarylowe użyteczne do leczenia chorób, w których pośredniczą TNF-ALFA i IL-1 - Google Patents

Związki pirazolo-heteroarylowe użyteczne do leczenia chorób, w których pośredniczą TNF-ALFA i IL-1

Info

Publication number: PL1833477T3
Authority: PL; Poland
Prior art keywords: alpha; pyrazolo; mediated diseases; compounds useful; heteroaryl compounds
Prior art date: 2004-12-16

Application number

PL05822740T

Other languages

English (en)

Inventor

Lászlo Révész

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-16

Filing date

2005-12-14

Publication date

2010-11-30

2005-12-14 Application filed by Novartis Ag filed Critical Novartis Ag

2010-11-30 Publication of PL1833477T3 publication Critical patent/PL1833477T3/pl

Links

201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
230000001404 mediated effect Effects 0.000 title abstract 2
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 abstract 1
102000000589 Interleukin-1 Human genes 0.000 abstract 1
108010002352 Interleukin-1 Proteins 0.000 abstract 1
108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 1
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Endocrinology (AREA)
Transplantation (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL05822740T 2004-12-16 2005-12-14 Związki pirazolo-heteroarylowe użyteczne do leczenia chorób, w których pośredniczą TNF-ALFA i IL-1 PL1833477T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0427604.4A GB0427604D0 (en)	2004-12-16	2004-12-16	Organic compounds
PCT/EP2005/013453 WO2006063820A1 (en)	2004-12-16	2005-12-14	Pyrazolo-heteroaryl compounds useful to treat tnf-alpha and il-1 mediated diseases
EP05822740A EP1833477B1 (en)	2004-12-16	2005-12-14	Pyrazolo-heteroaryl compounds useful to treat tnf-alpha and il-1 mediated diseases

Publications (1)

Publication Number	Publication Date
PL1833477T3 true PL1833477T3 (pl)	2010-11-30

Family

ID=34090176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05822740T PL1833477T3 (pl)	2004-12-16	2005-12-14	Związki pirazolo-heteroarylowe użyteczne do leczenia chorób, w których pośredniczą TNF-ALFA i IL-1

Country Status (17)

Country	Link
US (1)	US20090258874A1 (pl)
EP (1)	EP1833477B1 (pl)
JP (1)	JP2008524141A (pl)
KR (1)	KR20070087607A (pl)
CN (1)	CN101076333A (pl)
AT (1)	ATE469646T1 (pl)
AU (1)	AU2005315849B2 (pl)
BR (1)	BRPI0519337A2 (pl)
CA (1)	CA2586543A1 (pl)
DE (1)	DE602005021697D1 (pl)
ES (1)	ES2345207T3 (pl)
GB (1)	GB0427604D0 (pl)
MX (1)	MX2007007218A (pl)
PL (1)	PL1833477T3 (pl)
PT (1)	PT1833477E (pl)
RU (1)	RU2007126968A (pl)
WO (1)	WO2006063820A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2006283935A1 (en)	2005-08-25	2007-03-01	F. Hoffmann-La Roche Ag	Fused pyrazole as p38 MAP kinase inhibitors
CA2620105A1 (en) *	2005-08-25	2007-03-01	F. Hoffman-La Roche Ag	P38 map kinase inhibitors and methods for using the same
EP2491033A4 (en) *	2009-10-20	2013-03-13	Eiger Biopharmaceuticals Inc	AZAINDAZOLES FOR THE TREATMENT OF FLAVIVIRIDAE VIRUS INFECTION
US8362023B2 (en)	2011-01-19	2013-01-29	Hoffmann-La Roche Inc.	Pyrazolo pyrimidines
US11466017B2 (en)	2011-03-10	2022-10-11	Board Of Regents, The University Of Texas System	Heterocyclic inhibitors of PTPN11
WO2013017480A1 (en)	2011-07-29	2013-02-07	Cellzome Limited	Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
WO2013017479A1 (en)	2011-07-29	2013-02-07	Cellzome Limited	Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
WO2013041605A1 (en)	2011-09-20	2013-03-28	Cellzome Limited	Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors
WO2014113942A1 (en) *	2013-01-23	2014-07-31	Merck Sharp & Dohme Corp.	Btk inhibitors
AU2017274199B2 (en)	2016-05-31	2021-09-23	Board Of Regents, The University Of Texas System	Heterocyclic inhibitors of PTPN11
CA3098988A1 (en)	2018-05-02	2019-11-07	Jw Pharmaceutical Corporation	Heterocycle derivative
KR102611661B1 (ko)	2018-05-02	2023-12-08	나비레 파르마, 인코퍼레이티드	Ptpn11의 치환된 헤테로사이클릭 억제제
LT3833670T (lt)	2018-08-10	2024-06-25	Navire Pharma, Inc.	6-(4-amino-3-metil-2-oksa-8-azaspiro[4.5]dekan-8-il)-3-(2,3-dichlorfenil)-2-metilpirimidin-4(3h)-ono dariniai ir susiję junginiai kaip ptpn11 (shp2) inhibitoriai, skirti vėžiui gydyti
WO2022115326A1 (en) *	2020-11-25	2022-06-02	Reneo Pharmaceuticals, Inc.	Methods of making a ppar-delta agonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2309206T3 (es) *	2001-10-02	2008-12-16	Smithkline Beecham Corporation	Compuestos quimicos.
EP1485390B1 (en) *	2002-03-07	2008-10-08	F. Hoffman-la Roche AG	Bicyclic pyridine and pyrimidine p38 kinase inhibitors
TW200400034A (en) *	2002-05-20	2004-01-01	Bristol Myers Squibb Co	Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
KR101312736B1 (ko) *	2003-02-27	2013-09-27	팔라우 파르마 에스에이	피라졸로피리딘 유도체
AU2005219517A1 (en) *	2004-02-27	2005-09-15	F.Hoffmann-La Roche Ag	Heteroaryl-fused pyrazolo derivatives
KR100843526B1 (ko) *	2004-02-27	2008-07-03	에프. 호프만-라 로슈 아게	피라졸의 접합 유도체

2004
- 2004-12-16 GB GBGB0427604.4A patent/GB0427604D0/en not_active Ceased
2005
- 2005-12-14 ES ES05822740T patent/ES2345207T3/es not_active Expired - Lifetime
- 2005-12-14 MX MX2007007218A patent/MX2007007218A/es not_active Application Discontinuation
- 2005-12-14 JP JP2007545941A patent/JP2008524141A/ja active Pending
- 2005-12-14 DE DE602005021697T patent/DE602005021697D1/de not_active Expired - Lifetime
- 2005-12-14 CN CNA2005800426060A patent/CN101076333A/zh active Pending
- 2005-12-14 AT AT05822740T patent/ATE469646T1/de not_active IP Right Cessation
- 2005-12-14 PT PT05822740T patent/PT1833477E/pt unknown
- 2005-12-14 PL PL05822740T patent/PL1833477T3/pl unknown
- 2005-12-14 RU RU2007126968/04A patent/RU2007126968A/ru not_active Application Discontinuation
- 2005-12-14 BR BRPI0519337-0A patent/BRPI0519337A2/pt not_active IP Right Cessation
- 2005-12-14 AU AU2005315849A patent/AU2005315849B2/en not_active Ceased
- 2005-12-14 KR KR1020077013508A patent/KR20070087607A/ko not_active Withdrawn
- 2005-12-14 US US11/721,822 patent/US20090258874A1/en not_active Abandoned
- 2005-12-14 CA CA002586543A patent/CA2586543A1/en not_active Abandoned
- 2005-12-14 EP EP05822740A patent/EP1833477B1/en not_active Expired - Lifetime
- 2005-12-14 WO PCT/EP2005/013453 patent/WO2006063820A1/en not_active Ceased

Also Published As

Publication number	Publication date
KR20070087607A (ko)	2007-08-28
ATE469646T1 (de)	2010-06-15
RU2007126968A (ru)	2009-01-27
CN101076333A (zh)	2007-11-21
JP2008524141A (ja)	2008-07-10
MX2007007218A (es)	2007-08-14
EP1833477B1 (en)	2010-06-02
CA2586543A1 (en)	2006-06-22
ES2345207T3 (es)	2010-09-17
GB0427604D0 (en)	2005-01-19
BRPI0519337A2 (pt)	2009-01-20
PT1833477E (pt)	2010-08-20
AU2005315849B2 (en)	2009-05-28
US20090258874A1 (en)	2009-10-15
WO2006063820A1 (en)	2006-06-22
DE602005021697D1 (de)	2010-07-15
EP1833477A1 (en)	2007-09-19
AU2005315849A1 (en)	2006-06-22

Publication	Publication Date	Title
TW200602808A (en)	2006-01-16	Functionalized photoinitiators
MA32811B1 (fr)	2011-11-01	Nouveaux composés
TNSN07272A1 (en)	2008-12-31	Substituted bis aryl and heteroaryl compounds as selective 5ht 2a antagonists
MXPA06010097A (es)	2007-06-15	Inhibidores de dipeptidil peptidasa-iv.
UA91854C2 (ru)	2010-09-10	Фунгицидная комбинация действующих веществ
UA95298C2 (ru)	2011-07-25	Фенилзамещенные гетероарильные производные и их применение в качестве противоопухолевых средств
EA201170521A1 (ru)	2011-12-30	Новые соединения
MY155517A (en)	2015-10-30	Heterocyclic derivatives
EA200701114A1 (ru)	2007-12-28	Азоловые производные с антимускариновой активностью
TW200628463A (en)	2006-08-16	Heteroaryl compounds
MX2007003175A (es)	2007-05-18	Medicamentos que contienen compuestos de carbonilo y su uso.
PL1833477T3 (pl)	2010-11-30	Związki pirazolo-heteroarylowe użyteczne do leczenia chorób, w których pośredniczą TNF-ALFA i IL-1
TW200519202A (en)	2005-06-16	Modulation of eIF4E expression
TW200621779A (en)	2006-07-01	Process for the manufacture of dihydropteridinones
GEP20094679B (en)	2009-05-10	Dipeptidyl peptidase inhibitors
MX2010006143A (es)	2010-07-06	Azolilmetiloxiranos, su uso y agentes que lo contienen.
WO2008149353A3 (en)	2010-02-25	Telomerase activating compounds and methods of use thereof
TW200833678A (en)	2008-08-16	HCV protease inhibitorscross reference
TW200745004A (en)	2007-12-16	Novel compounds, their preparation and use
WO2006048242A3 (en)	2006-11-09	Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
EA201070519A1 (ru)	2010-12-30	Соединения тропана
PH12012501630A1 (en)	2019-07-03	Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
CR11423A (es)	2010-06-28	NUEVOS INHIBIDORES DE sEH Y SU USO
MX2009003081A (es)	2009-04-01	Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas.
MX2007005932A (es)	2007-06-20	1-alquinil-2-ariloxialquilamidas y su uso como fungicidas.